Cytotoxic necrotizing factor type 2 produced by virulent \u3ci\u3eEscherichia
coli\u3c/i\u3e modifies the small GTP-binding proteins Rho involved in
assembly of actin stress fibers by Oswald, Eric et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Uniformed Services University of the Health 
Sciences U.S. Department of Defense 
1994 
Cytotoxic necrotizing factor type 2 produced by virulent 
Escherichia coli modifies the small GTP-binding proteins Rho 
involved in assembly of actin stress fibers 
Eric Oswald 
Ecole National Vétérinaire de Toulouse, 
Motoyuki Sugai 
Hiroshima University 
Agnès Labigne 
Inserm National de la Santé et de la Recherche Médicale 
Henry C. Wu 
Uniformed Services University of the Health Sciences 
Carla Fiorentini 
Istituto Superiore di Sanitá 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/usuhs 
 Part of the Medicine and Health Sciences Commons 
Oswald, Eric; Sugai, Motoyuki; Labigne, Agnès; Wu, Henry C.; Fiorentini, Carla; Boquet, Patrice; and O'Brien, 
Alison D., "Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small 
GTP-binding proteins Rho involved in assembly of actin stress fibers" (1994). Uniformed Services 
University of the Health Sciences. 115. 
https://digitalcommons.unl.edu/usuhs/115 
This Article is brought to you for free and open access by the U.S. Department of Defense at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Uniformed Services 
University of the Health Sciences by an authorized administrator of DigitalCommons@University of Nebraska - 
Lincoln. 
Authors 
Eric Oswald, Motoyuki Sugai, Agnès Labigne, Henry C. Wu, Carla Fiorentini, Patrice Boquet, and Alison D. 
O'Brien 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/usuhs/
115 
Proc. Nati. Acad. Sci. USA
Vol. 91, pp. 3814-3818, April 1994
Microbiology
Cytotoxic necrotizing factor type 2 produced by virulent Escherichia
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ABSTRACT Cytotoxic necrotizing factor type 2 (CNF2)
produced by Escherichia coil strains isolated from i
and eitraintetnalinf s I a dermonecrotic toxin Of 110
kDa. We cloned the CNF2 gene fom a large pasmd carried
by an Escherichia co strain ated from a lamb with septi-
cemla. Hydropathy analysis of the deduced amino acid se-
quence revealed a largey hydropic protein with two poten-
tial hydrophobic transmembrane domains. The N-terminal
halfofCNF2 showed sriking homology (27% Identity and 80%
conserved residues) to the N-te l portion of Pasteurella
multocida toxin. Methylaminprotection experiments and im-
munofluorescence studies ggesed that CNF2 enters the
cytosol of the target cell throgh an acidic compartmnt and
induces there i of actin into stress fibers. Since the
formation of stress fibers In eukaryotic cells involves Rho
proteins, we radiolabeled these small GTP-bindlug proteins
from CNF2-treated and control cells with a Rho-specific ADP-
ribosyltransferase. The P3PJADP-ribosylated Rho proteins
frm CNF2-treated cells migrated sightly more slowly in
SDS/PAGE than did the labeled proteins from the control
cells. This shift In moblllty ofRho proteins in SDS/PAGE was
also observed when CNF2 and the RhoA protein were coex-
pressed inE. colt. We propose that Rho proteins are the targets
of CNF2 in m a cells.
Certain Escherichia coli strains isolated from humans or
animals with diarrhea or extraintestinal infections produce a
cytotoxic necrotizing factor (CNF) that causes multinucle-
ation in tissue culture cells and necrosis in the rabbit skin
(1-7). Two types of CNF have been described: CNF1,
produced by E. coli strains isolated from humans and animals
(1-6), and CNF2 (first named Vir cytotoxin), produced by E.
coli strains isolated from cows and sheep (2, 4, 7). CNF1 and
CNF2 are similar in size with an apparent molecular mass of
110-115 kDa in SDS/PAGE (8-10) and are immunologically
related (2, 4, 10). However, CNF1 and CNF2 are distinguish-
able by (i) the specific necrotic activity of CNF2 in mouse
footpads (11), (ii) the different responses ofCNF1 and CNF2
in cross-neutralization assays (2, 4, 7), and (Ni) the different
serogroups and other virulence factors associated with the E.
coli strains that produce these toxins (2, 12, 13). In addition,
CNF1 is chromosomally encoded (14), whereas CNF2 is
encoded by F-like plasmids (7) that were initially designated
as Vir plasmids (15-17).
Several lines of evidence support a role for CNF in E. coli
pathogenicity. First, 10o-40 of E. coli strains isolated from
humans and animals with diarrhea or extraintestinal infec-
tions produce CNF1 or CNF2 (1-6). Second, experimental
infections ofneonatal calves (18) and pigs (19) with CNF1- or
CNF2-producing strains suggest that CNF1 and CNF2 con-
tribute to the pathogenesis of colibacillosis. Third, CNFs are
potent toxins that cause tissue damage and death of the
animal host (20). Fourth, CNF1 can trigger the entry of
noninvasive bacteria into HEp-2 human epidermoid carci-
noma cells through phagosome-like organelles (21). This
induction of phagocytic behavior in human epithelial cells is
associated with the capacity of CNF1 to induce F-actin
assembly (22).
In this paper, we present the cloning and sequence analysis
of the gene encoding CNF2 and describe experiments which
led to the identification of its target in the mammalian cell.tt
MATERIALS AND METHODS
Clonug and Sequenclng of cnf2. DNA manipulations were
carried out by standard procedures (23). Vir plasmid DNA
was purified from E. coli 711(pVir) (15), partially digested by
Sau3Al, and ligated to BamHI-digested pILL570 plasmid
DNA (24). E. coli MC1061 (23) transformed with recombinant
plasmids was screened for the production ofCNF2 by the cell
cytotoxic assay (4), the rabbit skin test (2), and the mouse
footpad test (11). TnS mutagenesis of pEOAL6 was con-
ducted with the F',,1141ac::TnS plasmid (25). Subclones of
pEOAL6 and pEOAL10 were constructed in plasmid vectors
pBluescript II SK(+) (Stratagene) and pK184 (26). The
nucleotide sequence of double-stranded template DNA was
determined as described in the CircumVent thermal cycle
dideoxy DNA sequencing kit (New England Biolabs). DNA
and peptide sequence data were analyzed by the Genetics
Computer Group software package (27). CNF2 secondary
structure was predicted with the program developed by
Burkhard and Sander (28).
Radiolabeflug of Rho Proteins by ADP-ribosylation. Swiss
3T3 mouse cells were maintained in Dulbecco's modified
Eagle's medium containing 10%o fetal bovine serum. After a
24-hr incubation with CNF2 extracts, cells were washed
three times with cold phosphate-buffered saline, pooled by
scraping, pelleted by centrifugation, and homogenized by
Abbreviations: CNF, cytotoxic necrotizing factor; PMT, Pasteurella
multocida toxin.
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ttThe sequence of cnJ2 presented in this paper has been deposited in
the GenBank data base (accession no. U01097).
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sonication (29). The proteins in the resulting homogenates
were [32P]ADP-ribosylated in vitro with pure Staphylococcus
aureus epidermal cell differentiation inhibitor (EDIN) (30).
The standard reaction mixture (100 skd) contained 10 ALM
[a-32P]NAD (1000-3000 cpm/pmol), 40 ng of EDIN, and the
cell lysate. After 20 min at 30'C, proteins were precipitated
with 10% (wt/vol) trichloroacetic acid and analyzed by
SDS/12% PAGE. The same techniques were used to ADP-
ribosylate the RhoA protein present in sonic lysates ofE. coli
strains carrying pGC-RhoA and pK184 or pGC-RhoA and
pEOSW30. The pGC-RhoA plasmid contains RhoA cDNA
under the control of a tryptophan promoter (31). Samples of
E. coli strains were prepared by sonication of the cells from
a late-logarithmic-phase culture in Luria-Bertani (LB) me-
dium.
RESULTS
Cloning of the DNA Region of pVir Required for CNF2
Production. A common region of 5.15 kb was identified by
comparing the restriction maps of pEOAL6 and pEOAL10,
two subclones from pVir that caused multinucleation of
HEp-2 cells (Fig. 1). E. coli transformed with mutant plas-
mids containing TnS insertions mapped in this common
region did not produce CNF2 (Fig. 1). Additional evidence
that this 5.15-kb region contained the gene(s) responsible for
multinucleation was obtained by subcloning this region in a
pBluescript II SK(+) vector. First, the 350-bpBgl II fragment
ofpEOAL10 was ligated into BamHI-digested pBluescript II
SK(+). The resulting recombinant plasmid was digested with
Xba I/BamHI and ligated to the 4.8-kb Xba I-BamHI frag-
ment from pEOAL6. One such clone, pEOSW20, contained
the correct 5.15-kb insert and expressed CNF2 (Fig. 1).
Identification and Sequence of the Open Reading Frame
(ORF) Encoding CNF2. The region common to the CNF2-
producing clones was sequenced. An open reading frame
(ORF) of 3045 nucleotides was identified. This ORF was
85.7% identical to the recently sequenced gene encoding
CNF1 (14). The identification ofthe 3045-bp ORF as cnJ2 was
confirmed by subcloning the Ban I-Hae II DNA fragment
encompassing the ORF and the 112-bp region upstream ofthe
start codon. This 3332-bp Ban I-Hae II DNA fragment was
digested with mung bean nuclease and ligated into Sma
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I-digested pK184. The resulting clone, pEOSW30 (Fig. 1),
was transformed into E. coli XL1-blue; the lysate of E. coli
XL1-blue(pEOSW30) induced multinucleation ofHEp2 cells
and caused necrosis in the mouse footpad and in the rabbit
skin. By contrast, a similarly prepared lysate ofcontrol strain
E. coli XL1-blue(pK184) was not toxic in vitro or in vivo (data
not shown). Taken together, these results support our con-
clusion that the ORF cloned in pEOSW30 is cnJ2.
Analysis of the Deduced Amino Acid Sequence ofCNF2. cnJ2
encodes a protein of 1014 amino acids with a calculated
molecular weight of 114,659. Analysis of the deduced amino
acid sequence of CNF2 revealed an atypical codon usage for
E. coli which reflects the low G+C content of cnJ2 (35.3%).
The hydropathy profile predicted by the program ofKyte and
Doolittle (32) showed that CNF2 was a relatively hydrophilic
protein with two putative hydrophobic transmembrane do-
mains (amino acids 333-372 and 386-409). These two do-
mains were partially overlapped by two predicted a-helices
(amino acids 327-342 and 391-410). Most notably, no clas-
sical signal sequence was found in the N-terminal 50 residues
of CNF2. Beside the high homology between CNF2 and
CNF1 (the two toxins shared 85% identical residues and 99%o
conserved residues over 1014 amino acids; Fig. 2), a com-
parison of the predicted amino acid sequence of CNF2 with
sequences in GenBank (Release 80) revealed that the Pas-
teurella multocida toxin (PMT) shared 27% identical residues
and 80%o conserved residues over the N-terminal 528 amino
acids of CNF2 (Fig. 3). Similar findings were noticed in the
analysis of the deduced amino acid sequence of CNF1 (14).
We also observed 77% homology between CNF2 amino acids
399-426 and the glucose-binding domain of hexokinase B
from Saccharomyces cerevisiae (35) and 64% homology
between CNF2 amino acids 67-319 and the N terminus of the
epidermin-modifying enzyme EpiB of Staphylococcus epi-
dermidis (33) (data not shown).
Methylamine Protection ofHEp-2 Cells from CNF2 Toxicity.
To study the mechanism by which CNF2 enters and reaches
the cytoplasm in HEp-2 cells, various concentrations of
methylamine chloride (pH 7.4) were added to the culture
medium of subconfluent HEp-2 cells. Methylamine is an
agent that increases endosomal and lysosomal pH and
thereby inhibits the processing and translocation of many
toxins into the cell cytoplasm (34). An E. coli XL1-
CNF2 Effects
Multinucleation Necrosis
pEOAL6 +
pEOALI1 + +
pEOAL61
pEOAL62
pEOSW20 +
pEOSW30 +
+
+
3' cnf2 5'
ITn5 insertion
Ikb
FIG. 1. Restriction maps of various subclones of the Vir plasmid that contain cnJ2. The production of CNF2 after transformation into E.
coli XL1-blue or MC1061 is shown at right. The cloning vector for pEOAL6, pEOAL61, pEOAL62, and pEOAL10 was pILL570. The cloning
vector for pEOSW20 was pBluescript SK II(+). The cloning vector for pEOSW30 was pK184. Arrows indicate the 5' -* 3' orientation of the
IacZ gene in pBluescript SK II(+) and pK184. The restriction sites of relevant endonucleases are indicated: Ba, BamHI; Bg, Bgl II; Bn, Ban
I; C, Cla I; P, Pst I; H, Hae II; X, Xba I.
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CNF2 1 MNVQWQQKYLLEYNELVSNFPSPERVVSDYIRRCFKTDLPWFSQVDPDNT 50
CNF1 -GN--------------------------- KN ---------- RI----A
51 YFIRFSQSRSNSRSYTGWDHLGKYKTGVLTLTQAALINIGYHFDVFDDAN 100
---C---N------------------E--------------R--------
101 ASAGIYKTSSADMFNEKNEEKMLPSEYLYFLKGCDFSGIYGRFLSDYWSK 150
S-T----- K---V---E----------- H--QK---A-V--KT-------
151 YYDKFKLLLKNYYISSALYLYKNGEIDEYEYNFSISALNRRDNISLFFFD 200
------------------------- L--R-----MN ----S----- L---
201 IYGYYSSDMFVAKNNERVMLFIPGAKKPFLFEKNIADLRISLKNLIKEND 250
-----A--I----D--DK--------------K-------LT--E---DS-
251 NKQLLSQHFSLYSRQDGITYAGVNSVLNAIENDGVFNESYFLYSNKRINN 300
KQ--------------- VS--------H------N-----------TLS-
301 KDVFDAVAFSVKKRSFSDGDIVIKSNSEAQRDYALTILQTILSMTPIFDV 350
------I-I----------------------------------------I
351 AIPEVSVTLGLGI IASSMGISFDQLINGDTYEERRSAIPGLATNAALLGL 400
VV---- P----- T------------------------------V----
401 SFAIPFLISKAGTNQKILSRYTKHEIRTLNETNIDMFLEEYGINKNSISE 450
-----L------I--EV--SVINN-G--------- I--K----AED---S
451 TKVLEVELKGSGQHVNIVKLSDEDNKIVAVKGNSLSGIYYEVDIETGYEI 500
-NL-D-K--S-------------Q-------S-----------------
501 SSRRIYRTEYNDKIFWTRGGGLKGGQSFDFESLKLPIFFKDEPYSAVPGS 550
L----------NE-L----P-------HP-----NI-V---------- T--
551 SLSFINDDSSLLYPNSTPKLPQPTPEMEIVNYVKRAGNFGERLVTLMRGT 600
P-------------DTN-------S--D------GS-S--D-F------A
601 TEEEAWNIARYHTAGGSTEELHEILLGQGPQSSLGFTEYTSNINSADAAS 650
-S- V-
651
701
751
RRHFLVVIKVQVKYINNNNVSHVNHWAIPDEAPVEVLAVVDRRFNFPEPS
TPPNISI IHKLLSLRYFKENIESTSRLNLQKLNRGNIDIFKGRGSISSTR
---D--T-R----------S----- KS-F---S-----VL----------
QRAIYPYFESANADEQQPVFFYIKKNRFDDFGYDQYFYNSTVGLNGIPTL
1 MNVQWQQKYLLEYNELVSNFPSPERVVSDYIRRCFKTDLPWFSQVDPDNT 50
11:1:::: :::: 1:1 :1:1 :: ::1:
35 NNVKWKEVFINRFGQMMLDTPNPRKIVEKIINEGLEKQG--LKNIDPETT 82
51 YFIRFSQSRSNSRSYTGWDHLGKYKTGVLTLTQAALINI--GYHFDVFDD 98
83 YFNIFSSSDSSDGNVFHYNSLS----ESYRVTDACLMNIFVERYFDDWDL 128
99 AN--ASAGIYKTSSADMFNEKNE------------ EKMLPSEYLY-FLKG 133
129 LNSLASNGIYSVGKEGAYYPDHDYGPEYNPVWGPNEQIYHSRVIADILYA 178
134 CDFSGIYGRFLSDYWSKYYDKFKLLLKNYYISSALYLYKNGEIDEYEYNF 183
179 RSVWDEFKKYFMEYWQKYAQLYTEMLSDTFLAMAIQQYTRQTLTDEGFLM 228
184 SISA-LNRRDNISLFFFDIYGYYSSDMFVAKNNE ----RVMLFIPGAKKP 228
229 VCNTYYGNKEEVQITLLDIYGYPSTDIICIEQKGLPTPKVILYIPGGTQP 278
229 FLFEKNIADLRISLKNLIKENDNKQLLSQHFSLYSRQDGITYAGVNSVLN 278
279 FVEFLNTDDLKQWIAWHLKDNKHMVRFRKHFSLKQRQEGETFTGIDKALQ 328
279 AIENDGV--FNESYFLYSNKRINNKDVFDAVAFSVKKRSFSDGDIVIKSN 326
329 YIAEESPEWPANKYILYNPTHLETENLFNIMMKRTEQRMLEDSDVQIRSN 378
327 SEAQRDYALTILQTILSMTPIFDVAIPEVSVTLGLGI IASSMGISFDQLI 376
379 SEATRDYALSLLETFISQLSAIDMLVPAVGIPINFALSATALGLSSDIVV 428
377 NGDTYEERRSAIPGLATNAALLGLSFAIPFLISKAGTNQKILSRYTKHEI 426
429 NGDSYEKRKYGIGSLVQSALFTGINL-IP-VISETAEILSSFSR-TEEDI 475
427 RTL--NETNIDMFLEEYGINKNSISETKVLEVELKGSGQHVNIVKLSDED 474
476 PAFFTEEQALAQRFEIVEEELHSISPDDPPREITDENLHKIRLVRLNNEN 525
475 NKIVAVKGNSLSGIYYEVDIETGYEISSRRI--YRTEYNDKIFWTRGGGL 522
526 QPLVVLRRLG-GNKFIRIEPITFQEIKGSLVSEVINPVTNKTYYVSNAKL 574
523 KGGQSF 528
575 LGGSPY 580
700
750
800
801 NTYTGEILSDASSLGSTYWKKYNLTNETSIIRVSNSARGANGIKIALEEV 850
------PS-------------------------
851 QEGKPVI ITSGNLSGCTTIVARKGGYLYKVHTGTTIPLAGFTSTTGVKKA 900
-----------------------E--I--------KS-------------
901 VEVFELLTNNPMPRVEGVMNNDFLVNYLAESFDESLITYSSSEQKIGSKI 950
---L----KE-I------S------D--S-N-ED---------K-PD-Q-
951 TISRDNVSTFPYFLDNIPEKGFGTSVTILVRVDGNVIVKSLSESYSLNVE 1000
--I ------V ---------H----A-V------- V-R---------AD
1001 NSNISVLHVFSKDF* 1015
A-E-----K-----K--
FiG. 2. Similarity between the deduced amino acid sequences
from E. coli CNF2 (this study) and E. coli CNF1 (14). Identical
residues are indicated by dots, conserved residues by plain letters,
and nonconserved residues by boldface letters.
blue(pEOSW30) lysate that contained a CNF2 activity esti-
mated at 4 CD50 (4 times the median cytotoxic dose) was
added to the HEp2 cells treated with methylamine. The
percentage ofmultinucleated cells was measured after a 72-hr
incubation. We observed that the addition of methylamine 1
hr prior to the addition of the toxic extract protected the
HEp-2 cells from CNF2 toxicity in a dose-dependent manner.
Indeed, 5 mM methylamine reduced to 40%o the number of
multinucleated cells as cofnpared with untreated cells, and 10
mM methylamine completely inhibited the multinucleation
effect induced by CNF2 (data not shown). In contrast, no
protective effect was observed when the methylamine (up to
15 mM) was added 2 hr after CNF2 (data not shown). These
findings suggest that acidification of endosomes is required
for the expression ofCNF2 cytotoxicity. Similar results have
been observed with PMT (36).
CNF2-Inducd Assembly of F-Actfn. CNF1 mediates actin
assembly in intoxicated cells (22). We speculated therefore
that CNF2 might also cause the reorganization of F-actin,
based on the similar effects of CNF1 and CNF2 in inducing
multinucleation. To test this hypothesis, HEp-2 cells were
incubated for 24 hr with a CNF2-containing extract from E.
coli XL1-blue(pEOSW30) or, as a control, a similarly pre-
pared extract from E. coli XL1-blue(pK184). Cellular F-actin
from extract-treated cells was then stained with fluorescein
isothiocyanate-conjugated phalloidin (21). Lysates of E. coli
XLl-blue(pEOSW30) that contained CNF2 drastically mod-
ified the actin cytoskeleton of HEp-2 cells, whereas the
control lysate ofXLl-blue(pK184) had no such an effect (Fig.
4). The actin was reorganized into long thick filaments
(classically called stress fibers) in the CNF2-treated cells,
FIG. 3. Similarity between the deduced N-terminal amino acid
sequence of E. coli CNF2 and the N terminus ofPMT (43, 44). The
GAP program of the Genetics Computer Group package was used to
compare the deduced amino acid sequences ofCNF2 (upper line) and
PMT (lower line). Identical residues are indicated by vertical lines
and conserved residues by colons.
whereas the majority of F-actin remained diffuse in the
control-treated cells or untreated cells (data not shown). The
CNF2-induced actin filament reorganization preceded the
multinucleation that was observed 48-72 hr after exposure of
the HEp-2 cells to the toxin. We postulate, as has been
proposed for CNF1 (22), that treatment of HEp-2 cells with
CNF2 causes the reorganization of F-actin, which might
block cytokinesis during mitosis and subsequently lead to the
formation of multinucleated cells in culture.
CNF2-Modlfied Rho Proteins. It has been shown recently
that a possible intracellular target ofCNF1 in eukaryotic cells
could be the small GTP-binding proteins of the Rho family
(37). These proteins regulate the assembly of focal adhesion
and stress fibers in eukaryotic cells (38, 39). To determine
whether CNF2 mediates actin polymerization of intoxicated
cells through these small GTP-binding proteins, we radiola-
beled the Rho proteins from lysates of CNF2-treated Swiss
3T3 cells with a Rho-specific ADP-ribosyltransferase pro-
duced by Staphylococcus aureus (30). Nearly confluent
Swiss 3T3 cell cultures were incubated for 24 hr with a
CNF2-containing cell extract from E. coli XL1-blue-
(pEOSW30) or, as a control, a similarly prepared extract
from E. coil XL1-blue(pK184). The radiolabeled Rho pro-
teins from eukaryotic cells treated with CNF2 were shifted
toward higher molecular weight as compared with those from
control cells (Fig. SA). To further demonstrate the role of
CNF2 in the modification ofRho proteins in eukaryotic cells,
we tried to directly reproduce the shift in Rho protein
mobility observed in SDS/PAGE ofRhoA protein expressed
in E. coli. For this purpose, we transformed an E. coli strain
carrying a recombinant clone that expresses RhoA with
plasmid pK184 or pEOSW30 and tested the lysates for the
presence of modified RhoA. Both E. coli C600(pK184; pGC-
3816 hficrobiology: Oswald et aL
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FIG. 4. Fluoresceinated phalloidin-stained actin i
after 24 hr ofincubation with or without CNF2. (Upper
treated with an extract of E. coli XL1-blue(pK184).
treated with an extract ofE. coliXL1-blue(pEOSW30) 1
CNF2. (x500.)
RhoA) and C600(pEOSW30; pGC-RhoA) prodi
but only the latter strain produced CNF2. In thi
radiolabeled RhoA protein showed an apparent,
increase in molecular weight as compared to c
(Fig. SB). However, this molecular weight shift
ducibly larger in the eukaryotic cells (Fig. 5A)
prokaryotic cells (Fig. 5B). The biochemical 1
mobility shift ofCNF2-modified Rho proteins in
remains to be determined. To test the possibility
could be an ADP-ribosylating enzyme or an AT]
protein kinase, we treated Swiss 3T3 cell homoj
partially purified CNF2 extracts and either [3
[a-32P]ATP. SDS/PAGE followed by autoradi
not reveal any specific 32P-labeled proteins in th
cell homogenates treated with CNF2 (data not
A
<- 29.7
- 19.1
B
-
FIG. 5. Autoradiograms of the Rho proteins expi
karyotic or prokaryotic cells in the presence (+) or al
CNF2. Lysates of eukaryotic or prokaryotic cells were
analyzed. (A) Lysates of Swiss 3T3 cells treated with
E. coli XL1-blue(pK184) (-) or with an extract of
blue(pEOSW30) that contained CNF2 (+). (B) Lysates
coli C600(pK184; pGC-RhoA) (-) and of E. coli C6(
pGC-RhoA) that contained CNF2 (+). Position and siz
markers are shown at right.
similar finding was observed after microinjection ofthe toxin
into Xenopus oocytes loaded with (32P]NAD (P.B., unpub-
lished data). These preliminary experiments show that the
structural alteration of Rho proteins by CNF2 does not
involve NAD-dependent ADP-ribosylation or ATP-depen-
dent phosphorylation of Rho proteins.
DISCUSSION
Two major conclusions about CNF2 production and its
biological properties can be derived from this study. First,
CNF2 in E. coli is encoded by a single structural gene, cnJ2,
and the recombinant CNF2 is fully active in inducing multi-
nucleation in cultured eukaryotic cell lines and in causing
necrosis in both rabbit skin and mouse footpad. Second,
CNF2 is a potent cytotoxin which drastically modifies the
actin cytoskeleton of HEp-2 cells. The capacity of CNF2 to
mediate polymerization of F-actin suggests that this toxin,
like CNF1, may trigger the actin-dependent endocytosis of
bacteria (21). Based on these results and on the incidence of
CNF-producing strains in human and animal infections, we
believe that CNF2 may be an important virulence determi-
nant in E. coli strains that cause enteric and extraintestinal
infections.
The actin cytoskeleton is a key player not only in the
interactions of pathogenic bacteria with mammalian cells but
also in many cellular processes, including cell division and
growth control. Actin assembly in eukaryotic cells has been
shown to involve the Rho proteins (38, 39). This family of
Ras-related proteins is also involved in cell growth regulation
(40) and in the signal transduction pathway linking growth
n HEp2 cells factor receptors to the assembly of focal adhesions and the
(Lower) Cells organization of actin into stress fibers (41). In the presentLhat contained study, we have shown that Rho proteins in CNF2-treatedcells were shifted toward a higher molecular weight in
SDS/PAGE. We were able to reproduce this shift when
uced RhoA, CNF2 and RhoA were coexpressed in E. coli. This result
is strain, the strongly supports a direct interaction between CNF2 and the
albeit small Rho proteins and demonstrates that the modification of Rho
control cells proteins by CNF2 does not require prior C-terminal modifi-
t was repro- cation and processing by enzymes unique to eukaryotic cells.
tthan in the The effects of CNF2 on the actin cytoskeleton mimic those
basis of the observed when a constitutively activated mutant of RhoA,
SDS/PAGE I[Val14]RhoA, is microinjected into Swiss 3T3 cells (39). We
y that CNF2 propose that CNF2 covalently modifies the structure of Rho
P-dependent protein in such a way that the modified Rho protein is
t with functionally hyperactive as compared with its native form.genates This hyperactive state may be a reflection of an altered
ogap]NA ord interaction of activated Rho proteins with its target or withographydid other accessory proteins such as the GTPase-activating pro-
teswn).3 teins and GDP-dissociation inhibitors (42). Although we havehown) A not identified the mechanism of CNF2 action, the amino acid
homology between CNF2 and EpiB, a protein involved in the
posttranslational modification ofepidermin (33), may provide
-~---- 29.7 some clues to the nature of the CNF2-induced modification
of Rho proteins.
The mechanism by which CNF2 is delivered to the host cell
during an infection remains unclear. Analysis of the deduced
amino acid sequence of CNF2 showed the absence of a
_a----19.1 consensus signal sequence. This result was not surprising
since most of the CNF2 activity was found in the cytoplasm
of the bacteria after 24-hr shaking culture in tryptic soy broth
ressed by eu- (TSB) or LB broth (data not shown). However, since labo-
bsence (-) of ratory culture conditions do not necessarily reflect the in vivo
an extract of environment of the host during an infection, we cannot rule
E. cole Xo out the possibility that the toxin is secreted through an
of control E. inducible excretion machinery in the in vivo environment.I0(pEOSW3fo Alternatively, lysis of some bacteria may release enough
e (kDa) of the toxin to modify the cytoskeleton of the host cell without
active secretion of CNF2. Indeed, picomolar concentrations
Nficrobiology: Oswald et al.
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ofCNF1 are sufficient to induce F-actin polymerization (21),
and we have also found that the supernatant of a 24-hr TSB
broth culture from a CNF2-producing strain contains enough
toxin to modify the cytoskeleton of HEp-2 cells (data not
shown).
Although there is no report of a multinucleating effect of
PMT on cultivated cells, the homology observed between the
N-terminal region of CNF2 and the 145-kDa PMT is intrigu-
ing for several reasons. First, PMT, which is the primary
virulence determinant of strains of P. multocida that cause
progressive rhinitis in pigs, has no significant homology to
any protein except CNF2 and CNF1 (refs. 14, 43, and 44; this
report). Second, like CNF2, PMT is a nonsecreted protein
without a typical signal sequence (43, 44) that induces der-
monecrotic lesions in animals and enters the cytoplasm of
target cells via an acidic compartment (36). Third, PMT is a
potent mitogen that appears to facilitate the coupling of
heterotrimeric GTP-binding protein to phosphatidylinositol-
specific phospholipase C which, in turn, stimulates the for-
mation of inositol phosphate (45). This interaction of both
PMT and CNF2 with a GTP-binding protein may indicate a
link between the modes of action ofPMT and CNF. Prelim-
inary results indicate that CNF2, like PMT, can induce DNA
synthesis in quiescent cells. Because PMT and CNF2 share
several common characteristics, we propose that the CNF
toxins and PMT are members of a heretofore unrecognized
family of toxins which modify GTP-binding proteins in a
novel way. We believe that PMT and CNF, and functionally
similar proteins yet to be discovered, will provide unique
molecular tools to elucidate cellular and molecular regulatory
mechanisms of eukaryotic cells.
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